Nerveda's Series B Round

Nerveda raised a round of funding on September 21, 2011. Investors include CBRE Group.

Nerveda is a life science seed fund dedicated to advancing pharmaceutical and diagnostic technologies for neurological disorders.…

Articles about Nerveda's Series B Round: